Si-Cong Ma

685 total citations
21 papers, 391 citations indexed

About

Si-Cong Ma is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Si-Cong Ma has authored 21 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Si-Cong Ma's work include Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Treatments and Mutations (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Si-Cong Ma is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Treatments and Mutations (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Si-Cong Ma collaborates with scholars based in China, United States and Germany. Si-Cong Ma's co-authors include Zhong‐Yi Dong, Dehua Wu, Li Liu, Hongbo Zhu, Xue‐Jun Guo, Yan-Pei Zhang, Xue Bai, Yuwen Lu, Yan Li and Weijia Lu and has published in prestigious journals such as Nature Communications, Cancer Research and Annals of Oncology.

In The Last Decade

Si-Cong Ma

15 papers receiving 387 citations

Peers

Si-Cong Ma
Kwangil Yim South Korea
Junjie Kuang China
Saba Shafi United States
Bernadette Redd United States
Kate Lillard Japan
John Arne Nesheim Norway
Felipe Batalini United States
Yaron Kinar Israel
John Maddison United Kingdom
Philipp Stenzel Germany
Kwangil Yim South Korea
Si-Cong Ma
Citations per year, relative to Si-Cong Ma Si-Cong Ma (= 1×) peers Kwangil Yim

Countries citing papers authored by Si-Cong Ma

Since Specialization
Citations

This map shows the geographic impact of Si-Cong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Si-Cong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Si-Cong Ma more than expected).

Fields of papers citing papers by Si-Cong Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Si-Cong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Si-Cong Ma. The network helps show where Si-Cong Ma may publish in the future.

Co-authorship network of co-authors of Si-Cong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Si-Cong Ma. A scholar is included among the top collaborators of Si-Cong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Si-Cong Ma. Si-Cong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Xin, Yuhao Wang, Xiaodie Li, et al.. (2025). Nano‐Mediated Fluorescence Switching for Epidermal Growth Factor Receptor Detection. Cell Proliferation. 58(12). e70063–e70063.
2.
3.
Zhang, Yan-Pei, et al.. (2024). Regular Use of Aspirin and Statins Reduces the Risk of Cancer in Individuals with Systemic Inflammatory Diseases. Cancer Research. 84(11). 1889–1897. 8 indexed citations
4.
5.
Zhou, Min, Jun Jiang, Kaican Cai, & Si-Cong Ma. (2024). MA16.05 PIEZO1+ Caner-associated Fibroblasts Shape an Inert Microenvironment to Suppress Anticancer Immunity in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 19(10). S122–S122.
6.
Wei, Wei, Jian Wang, He-San Luo, et al.. (2024). HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort study. BMC Medicine. 22(1). 443–443.
7.
Bai, Xue, Ze-Qin Guo, Yan-Pei Zhang, et al.. (2023). CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy. Nature Communications. 14(1). 1247–1247. 35 indexed citations
8.
9.
Ma, Si-Cong, Ze-Qin Guo, Yan-Pei Zhang, et al.. (2022). PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer. Cancer Research. 83(4). 568–581. 19 indexed citations
10.
11.
Ma, Si-Cong, Hongbo Zhu, Jian Wang, et al.. (2021). De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma. Frontiers in Oncology. 11. 666145–666145. 4 indexed citations
12.
13.
Yin, Wenjing, et al.. (2021). Efficacy and Treatment Strategies in Advanced Cancers with Liver Metastasis Receiving Atezolizumab Therapy. Cancer Management and Research. Volume 13. 4541–4551. 4 indexed citations
14.
Su, Shan, Xue Bai, Zhihao Huang, et al.. (2021). Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage. BMC Medicine. 19(1). 322–322. 7 indexed citations
15.
Ma, Si-Cong, Xin-Ran Tang, Xue Bai, et al.. (2021). Integrative evaluation of primary and metastatic lesion spectrum to guide anti-PD-L1 therapy of non-small cell lung cancer: results from two randomized studies. OncoImmunology. 10(1). 1909296–1909296. 14 indexed citations
16.
Zhang, Chaoying, et al.. (2021). Deep Learning in Video Violence Detection. 3 indexed citations
17.
Li, Pu, Yan-Pei Zhang, Hongbo Zhu, et al.. (2020). Development and Validation of a Deep Learning-Based Model Using Computed Tomography Imaging for Predicting Disease Severity of Coronavirus Disease 2019. Frontiers in Bioengineering and Biotechnology. 8. 898–898. 63 indexed citations
18.
Cao, Rui, Fan Yang, Si-Cong Ma, et al.. (2020). Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer. Theranostics. 10(24). 11080–11091. 163 indexed citations
19.
Bai, Xue, Dehua Wu, Si-Cong Ma, et al.. (2020). Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study. Journal for ImmunoTherapy of Cancer. 8(1). e000381–e000381. 45 indexed citations
20.
Ma, Si-Cong, et al.. (2019). Intelligence to Artificial Creativity. International Journal of Performability Engineering.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kwangil Yim Breakdown of academic impact, for papers by Junjie Kuang Breakdown of academic impact, for papers by Saba Shafi Breakdown of academic impact, for papers by Bernadette Redd Breakdown of academic impact, for papers by Kate Lillard Breakdown of academic impact, for papers by John Arne Nesheim Breakdown of academic impact, for papers by Felipe Batalini Breakdown of academic impact, for papers by Yaron Kinar Breakdown of academic impact, for papers by John Maddison Breakdown of academic impact, for papers by Philipp Stenzel
Rankless by CCL
2026